Azacitidine, sold under the brand name Vidaza among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, [5] [6] and juvenile myelomonocytic …

Azacitidine injection is used to treat patients with French-American-British (FAB) myelodysplastic syndrome (bone marrow problem) subtypes, including refractory anemia or chronic leukemia. …

Oct 9, 2024 · What is azacitidine? Azacitidine oral is used to treat acute myeloid leukemia in people who are in remission but cannot finish other treatments for this condition. Azacitidine …

It is used in adults with certain types of myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is used in children aged 1 month and older with newly diagnosed …

Azacitidine is a type of chemotherapy drug. It is also known as Vidaza. It is a treatment for people who can’t have high dose treatment with a stem cell transplant or bone marrow transplant for …

Mar 1, 2025 · Azacitidine is used to treat acute myeloid leukemia (AML) in patients who had a first complete remission (CR), following intensive induction cancer treatment with or without …

Find patient medical information for azacitidine oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Azacitidine is a type of chemotherapy. It is best to read this information about azacitidine with our general information about chemotherapy and the type of blood cancer you have. Azacitidine …

Azacitidine is used to treat acute myeloid leukemia (AML; cancer of the white blood cells) in adults who improved after chemotherapy, but who are unable to complete intensive curative therapy. …

Azacitidine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood …